TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Quantum BioPharma Ltd. Provides Corporate Update

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Zeeshan Saeed
Quantum BioPharma Ltd. Provides Corporate Update

Quantum BioPharma has entered an at-the-market offering agreement with H.C. Wainwright & Co. to potentially sell up to $21,225,000 in Class B Shares, with proceeds intended to fund clinical studies, research and development, and general corporate purposes.

Insights
QNTM   neutral

The company is raising capital through a standard at-the-market offering, which indicates a typical financing strategy without significant positive or negative implications